Previous Article | Next Article 
Journal of Virology, July 2000, p. 6675-6679, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Analysis of the CD4+ T-Cell
Response to Epstein-Barr Virus: T-Cell-Mediated Activation of Resting B
Cells and Induction of Viral BZLF1 Expression
Zheng
Fu
and
Martin J.
Cannon*
Department of Microbiology and Immunology,
University of Arkansas for Medical Sciences, Little Rock, Arkansas
72205
Received 18 January 2000/Accepted 26 April 2000
In contrast to the major role played by Epstein-Barr virus
(EBV)-specific CD8+ cytotoxic T-cell responses in
immunosurveillance, recent studies have offered the apparently
paradoxical suggestion that development of EBV-driven human B-cell
lymphoproliferative disorders and tumors in SCID/hu mice is dependent
on the presence of T cells, in particular CD4+ T cells.
This study presents a functional analysis of the CD4+
T-cell response to EBV and shows that while CD4+ T cells
may be cytotoxic, they also express Th2 cytokines and CD40 ligand
(gp39) and possess B-cell helper function. We show that EBV-specific
CD4+ T cells can provide non-HLA-restricted help for
activation of resting B cells via a gp39-CD40-dependent pathway and are
able to induce expression of BZLF1, a viral lytic cycle transactivator in latently infected resting B cells, ultimately resulting in rapid
outgrowth of transformed B-cell colonies. These results support the
proposal that CD4+ T cells may play a key role in
reactivation of latent EBV infection and may thus contribute to the
pathogenesis of EBV-driven lymphoproliferative disorders.
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Mail Slot 511, University of Arkansas for Medical Sciences, 4301 W. Markham, Little Rock, AR 72205. Phone: (501)
296-1254. Fax: (501) 686-5359. E-mail:
cannonmartin{at}exchange.uams.edu.

Present address: Department of Microbiology and Immunology,
University of Michigan Medical School, Ann Arbor, MI
48109.
Journal of Virology, July 2000, p. 6675-6679, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, A., Claesson, H.-E., Mahshid, Y., Klein, G., Klein, E.
(2008). Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures. Blood
111: 2693-2703
[Abstract]
[Full Text]
-
MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J.
(2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol.
81: 4766-4775
[Abstract]
[Full Text]
-
Piriou, E., Jansen, C. A., Dort, K. v., De Cuyper, I., Nanlohy, N. M., Lange, J. M. A., van Oers, M. H. J., Miedema, F., van Baarle, D.
(2005). Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy. J. Immunol.
175: 2010-2017
[Abstract]
[Full Text]
-
Gudgeon, N. H., Taylor, G. S., Long, H. M., Haigh, T. A., Rickinson, A. B.
(2005). Regression of Epstein-Barr Virus-Induced B-Cell Transformation In Vitro Involves Virus-Specific CD8+ T Cells as the Principal Effectors and a Novel CD4+ T-Cell Reactivity. J. Virol.
79: 5477-5488
[Abstract]
[Full Text]
-
Liu, A., Arbiser, J. L., Holmgren, A., Klein, G., Klein, E.
(2005). PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. Blood
105: 1606-1613
[Abstract]
[Full Text]
-
Stebbing, J., Gazzard, B., Mandalia, S., Teague, A., Waterston, A., Marvin, V., Nelson, M., Bower, M.
(2004). Antiretroviral Treatment Regimens and Immune Parameters in the Prevention of Systemic AIDS-Related Non-Hodgkin's Lymphoma. JCO
22: 2177-2183
[Abstract]
[Full Text]
-
Kanamori, M., Watanabe, S., Honma, R., Kuroda, M., Imai, S., Takada, K., Yamamoto, N., Nishiyama, Y., Kawaguchi, Y.
(2004). Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells. J. Virol.
78: 3984-3993
[Abstract]
[Full Text]
-
Asada, H., Miyagawa, S., Sumikawa, Y., Yamaguchi, Y., Itami, S., Suguri, S., Harada, M., Tokura, Y., Ishihara, S., Ohshima, S., Yoshikawa, K.
(2003). CD4+ T-Lymphocyte-Induced Epstein-Barr Virus Reactivation in a Patient With Severe Hypersensitivity to Mosquito Bites and Epstein-Barr Virus-Infected NK Cell Lymphocytosis. Arch Dermatol
139: 1601-1607
[Abstract]
[Full Text]
-
Nikiforow, S., Bottomly, K., Miller, G., Munz, C.
(2003). Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol.
77: 12088-12104
[Abstract]
[Full Text]
-
Khanolkar, A., Fu, Z., Underwood, L. J., Bondurant, K. L., Rochford, R., Cannon, M. J.
(2003). CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells. J. Immunol.
170: 3187-3194
[Abstract]
[Full Text]
-
Wilson, A. D., Morgan, A. J.
(2002). Primary Immune Responses by Cord Blood CD4+ T Cells and NK Cells Inhibit Epstein-Barr Virus B-Cell Transformation In Vitro. J. Virol.
76: 5071-5081
[Abstract]
[Full Text]